+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global mRNA Therapeutics Market by Type (Prophylactic Vaccines, Therapeutic Drugs, Therapeutic Vaccines), Application (Infectious Diseases, Oncology, Rare Genetic Diseases), End Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666329
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The mRNA Therapeutics Market size was estimated at USD 33.82 billion in 2023, USD 41.99 billion in 2024, and is expected to grow at a CAGR of 24.65% to reach USD 158.20 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the mRNA Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the mRNA Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the mRNA Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abogen Biosciences, Alnylam Pharmaceuticals, Inc., Arcturus Therapeutics, AstraZeneca plc, BioNTech SE, CRISPR Therapeutics AG, Deep Genomics, Eli Lilly and Company, GSK plc, Laronde Inc., Moderna, Inc., Nutcracker Therapeutics, Inc., Sangamo Therapeutics, Inc., Sarepta Therapeutics, Inc., Tracxn Technologies Limited, and Translate Bio, Inc. by Sanofi S.A.

Market Segmentation & Coverage

This research report categorizes the mRNA Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Prophylactic Vaccines
    • Therapeutic Drugs
    • Therapeutic Vaccines
  • Application
    • Infectious Diseases
    • Oncology
    • Rare Genetic Diseases
    • Respiratory Diseases
  • End Use
    • Hospitals & Clinics
    • Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the mRNA Therapeutics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the mRNA Therapeutics Market?
  3. What are the technology trends and regulatory frameworks in the mRNA Therapeutics Market?
  4. What is the market share of the leading vendors in the mRNA Therapeutics Market?
  5. Which modes and strategic moves are suitable for entering the mRNA Therapeutics Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. mRNA Therapeutics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of chronic and infectious diseases
5.1.1.2. Growing demand for cancer vaccines and treatments
5.1.1.3. Upsurge demand for mRNA therapeutics and proliferation of government initiatives for large scale sequencing projects
5.1.2. Restraints
5.1.2.1. High cost of research and threat of failure in quantification of mRNA
5.1.3. Opportunities
5.1.3.1. Significant biotechnology-related research and development (R&D) initiatives and advancements in medical technology
5.1.3.2. Development of personalized therapeutics for cancer with strong pipeline of new products
5.1.4. Challenges
5.1.4.1. Regulatory concerns and strategies for mRNA therapeutics
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. mRNA Therapeutics Market, by Type
6.1. Introduction
6.2. Prophylactic Vaccines
6.3. Therapeutic Drugs
6.4. Therapeutic Vaccines
7. mRNA Therapeutics Market, by Application
7.1. Introduction
7.2. Infectious Diseases
7.3. Oncology
7.4. Rare Genetic Diseases
7.5. Respiratory Diseases
8. mRNA Therapeutics Market, by End Use
8.1. Introduction
8.2. Hospitals & Clinics
8.3. Research Organizations
9. Americas mRNA Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific mRNA Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa mRNA Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abogen Biosciences
13.1.2. Alnylam Pharmaceuticals, Inc.
13.1.3. Arcturus Therapeutics
13.1.4. AstraZeneca plc
13.1.5. BioNTech SE
13.1.6. CRISPR Therapeutics AG
13.1.7. Deep Genomics
13.1.8. Eli Lilly and Company
13.1.9. GSK plc
13.1.10. Laronde Inc.
13.1.11. Moderna, Inc.
13.1.12. Nutcracker Therapeutics, Inc.
13.1.13. Sangamo Therapeutics, Inc.
13.1.14. Sarepta Therapeutics, Inc.
13.1.15. Tracxn Technologies Limited
13.1.16. Translate Bio, Inc. by Sanofi S.A.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. MRNA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. MRNA THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. MRNA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MRNA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MRNA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MRNA THERAPEUTICS MARKET DYNAMICS
FIGURE 7. MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2023 VS 2030 (%)
FIGURE 12. MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. MRNA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. MRNA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. MRNA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. MRNA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. MRNA THERAPEUTICS MARKET SIZE, BY PROPHYLACTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. MRNA THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MRNA THERAPEUTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MRNA THERAPEUTICS MARKET SIZE, BY RARE GENETIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MRNA THERAPEUTICS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 15. MRNA THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. MRNA THERAPEUTICS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 27. CANADA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 30. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 44. CHINA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 47. INDIA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 53. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 71. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 84. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 87. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 99. ITALY MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 108. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 111. POLAND MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 114. QATAR MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 135. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 144. MRNA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. MRNA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. MRNA THERAPEUTICS MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abogen Biosciences
  • Alnylam Pharmaceuticals, Inc.
  • Arcturus Therapeutics
  • AstraZeneca plc
  • BioNTech SE
  • CRISPR Therapeutics AG
  • Deep Genomics
  • Eli Lilly and Company
  • GSK plc
  • Laronde Inc.
  • Moderna, Inc.
  • Nutcracker Therapeutics, Inc.
  • Sangamo Therapeutics, Inc.
  • Sarepta Therapeutics, Inc.
  • Tracxn Technologies Limited
  • Translate Bio, Inc. by Sanofi S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 41.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 158.2 Billion
Compound Annual Growth Rate24.6%
Regions CoveredGlobal

Related Topics

Related Reports

mRNA Therapeutics Market Size, Share & Trends Analysis Report By Application (Rare Genetic Diseases, Oncology, Respiratory Diseases, Infectious Diseases), By Type (Prophylactic, Therapeutic), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

mRNA Therapeutics Market Size, Share & Trends Analysis Report By Application (Rare Genetic Diseases, Oncology, Respiratory Diseases, Infectious Diseases), By Type (Prophylactic, Therapeutic), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Global mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Application, Indication, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Application, Indication, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 144 Pages
  • Global
From
mRNA: Therapeutics and Global Markets - Product Image

mRNA: Therapeutics and Global Markets

  • Report
  • 171 Pages
  • Global
From
mRNA Therapeutics Market Report 2024 - Product Image

mRNA Therapeutics Market Report 2024

  • Report
  • 175 Pages
  • Global
From
mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 183 Pages
  • Global
From

About the mRNA Therapeutics Market

The mRNA Therapeutics market is a subset of the larger Genomics market, which focuses on the development of therapeutics based on messenger RNA (mRNA). mRNA is a type of genetic material that is used to produce proteins in cells. mRNA Therapeutics are designed to target specific diseases by delivering mRNA molecules to cells, which can then be used to produce proteins that can treat or prevent the disease. mRNA Therapeutics have the potential to revolutionize the way diseases are treated, as they can be used to target specific diseases without affecting other parts of the body. The mRNA Therapeutics market is still in its early stages, but is expected to grow rapidly in the coming years. Companies in the market are focused on developing mRNA-based therapeutics for a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders. Some of the companies in the mRNA Therapeutics market include Moderna, CureVac, Arcturus Therapeutics, and BioNTech. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.